"Clostridium Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus CLOSTRIDIUM.
| Descriptor ID |
D003015
|
| MeSH Number(s) |
C01.252.410.222
|
| Concept/Terms |
Clostridium Infections- Clostridium Infections
- Infections, Clostridium
- Clostridium Infection
- Infection, Clostridium
Clostridium difficile Infection- Clostridium difficile Infection
- Clostridium difficile Infections
- Infection, Clostridium difficile
- Infections, Clostridium difficile
Clostridium sordellii Infection- Clostridium sordellii Infection
- Clostridium sordellii Infections
- Infection, Clostridium sordellii
- Infections, Clostridium sordellii
Clostridium perfringens Infections- Clostridium perfringens Infections
- Clostridium perfringens Infection
- Infection, Clostridium perfringens
- Infections, Clostridium perfringens
|
Below are MeSH descriptors whose meaning is more general than "Clostridium Infections".
Below are MeSH descriptors whose meaning is more specific than "Clostridium Infections".
This graph shows the total number of publications written about "Clostridium Infections" by people in this website by year, and whether "Clostridium Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 4 | 1 | 5 |
| 2011 | 7 | 0 | 7 |
| 2012 | 6 | 2 | 8 |
| 2013 | 7 | 0 | 7 |
| 2014 | 4 | 0 | 4 |
| 2015 | 5 | 1 | 6 |
| 2016 | 5 | 0 | 5 |
| 2017 | 9 | 0 | 9 |
| 2018 | 15 | 0 | 15 |
| 2019 | 13 | 1 | 14 |
| 2020 | 13 | 1 | 14 |
| 2021 | 17 | 1 | 18 |
| 2022 | 13 | 0 | 13 |
| 2023 | 14 | 1 | 15 |
| 2024 | 6 | 3 | 9 |
| 2025 | 6 | 4 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clostridium Infections" by people in Profiles.
-
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk. J Infect Dis. 2025 Dec 20; 232(6):1446-1456.
-
New investigational agents for the treatment of Clostridioides difficile infections. Expert Opin Investig Drugs. 2025 Nov; 34(11):869-885.
-
Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study. Lancet Microbe. 2025 Aug; 6(8):101126.
-
Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infection. Cell Rep. 2025 Apr 22; 44(4):115438.
-
A thiouracil desulfurase protects Clostridioides difficile RNA from 4-thiouracil incorporation, providing a competitive advantage in the gut. Cell Host Microbe. 2025 Apr 09; 33(4):573-588.e7.
-
Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes. mSystems. 2025 Mar 18; 10(3):e0107524.
-
The impact of ibezapolstat and other Clostridioides difficile infection-relevant antibiotics on the microbiome of humanized mice. Antimicrob Agents Chemother. 2025 04 02; 69(4):e0160424.
-
The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae. Antimicrob Agents Chemother. 2025 04 02; 69(4):e0167924.
-
Control of Clostridioides difficile virulence and physiology by the flagellin homeostasis checkpoint FliC-FliW-CsrA in the absence of motility. mBio. 2025 Mar 12; 16(3):e0380124.
-
Clostridioides difficile colonization is not mediated by bile salts and utilizes Stickland fermentation of proline in an in vitro model. mSphere. 2025 Feb 25; 10(2):e0104924.